Similar to AD, other neurodegenerative diseases such as Parkinson’s are characterized by dysregulated glucose metabolism67 and serum metabolome signatures68—these could potentially be linked to altered GLUT1 expression. Here, SLC2A1 is linked to Parkinson disease.